calcipotriene and Neurofibroma--Plexiform

calcipotriene has been researched along with Neurofibroma--Plexiform* in 1 studies

Other Studies

1 other study(ies) available for calcipotriene and Neurofibroma--Plexiform

ArticleYear
Calcipotriol Enhances Efficacy of Imatinib and Nilotinib on Cells Derived from Plexiform Neurofibroma.
    Anticancer research, 2021, Volume: 41, Issue:7

    Plexiform neurofibromas (PNFs) are benign tumors composed mainly of tumorous Schwann cells and non-tumorous fibroblasts. This study examined the possible enhancing effect of vitamin D on the efficacy of drugs used for the treatment of PNF in vitro.. Paired Schwann cells and fibroblasts were cultured from 10 PNFs and treated with imatinib and nilotinib in the absence and presence of calcipotriol, an analogue of the active metabolite of vitamin D. IC. Calcipotriol reduced the IC. Calcipotriol enhanced the efficacy of imatinib and nilotinib on PNF-derived cells in vitro, though rather non-specifically. Nevertheless, sustaining vitamin D at 100-200 nM, the physiological range, may be beneficial for reducing the dose of drugs without scarifying efficacy.

    Topics: Calcitriol; Cell Proliferation; Fibroblasts; Humans; Imatinib Mesylate; Neurofibroma, Plexiform; Pyrimidines; Schwann Cells; Vitamin D

2021